Global Cancer Stem Cell Therapeutics Market 2019-2023
SKU ID : TNV-14326695 | Publishing Date : 29-May-2019 | No. of pages : 104
Detailed TOC of Global Cancer Stem Cell Therapeutics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY TYPE
Market segmentation by type
Comparison by type
Allogeneic stem cell transplant - Market size and forecast 2018-2023
Autologous stem cell transplant - Market size and forecast 2018-2023
Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Increasing research activity on cancer stem cell key signaling pathways
Availability of stem cell markers in the identification of cancer stem cells
Development of first-in-class therapeutics using induced pluripotent stem cells
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Cellerant Therapeutics, Inc.
Celularity Inc.
Gamida Cell Ltd.
Nohla Therapeutics, Inc.
Sumitomo Dainippon Pharma Co. Ltd.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Type - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Allogeneic stem cell transplant - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Allogeneic stem cell transplant - Year-over-year growth 2019-2023 (%)
Exhibit 21: Allogeneic stem cell transplants under development
Exhibit 22: Autologous stem cell transplant - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Autologous stem cell transplant - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Late-stage cancer stem cell therapy
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Cellerant Therapeutics Inc. - Vendor overview
Exhibit 46: Cellerant Therapeutics Inc. - Key offerings
Exhibit 47: Celularity Inc. - Vendor overview
Exhibit 48: Celularity Inc. - Key offerings
Exhibit 49: Gamida Cell Ltd. - Vendor overview
Exhibit 50: Gamida Cell Ltd. - Business segments
Exhibit 51: Gamida Cell Ltd. - Key offerings
Exhibit 52: Nohla Therapeutics Inc. - Vendor overview
Exhibit 53: Nohla Therapeutics Inc. - Key offerings
Exhibit 54: Sumitomo Dainippon Pharma Co. Ltd. - Vendor overview
Exhibit 55: Sumitomo Dainippon Pharma Co. Ltd. - Business segments
Exhibit 56: Sumitomo Dainippon Pharma Co. Ltd. - Organizational developments
Exhibit 57: Sumitomo Dainippon Pharma Co. Ltd. - Segment focus
Exhibit 58: Sumitomo Dainippon Pharma Co. Ltd. - Key offerings
Exhibit 59: Validation techniques employed for market sizing
Exhibit 60: Definition of market positioning of vendors
Keyplayers in Global Cancer Stem Cell Therapeutics Market 2019-2023
Cellerant Therapeutics, Inc.Celularity Inc.
Gamida Cell Ltd.
Nohla Therapeutics, Inc.
Sumitomo Dainippon Pharma Co. Ltd.